Clinical trials
Completed Thalassemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 9 |
| Ente Ospedaliero Ospedali Galliera | 2 |
| ApoPharma | 1 |
| Celgene | 1 |
| Federico II University | 1 |
| Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia | 1 |
| Forma Therapeutics, Inc. | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 17 |
| beta-Thalassemia | 8 |
| Iron Overload | 5 |
| Anemia | 4 |
| Anemia, Diamond-Blackfan | 4 |
| Myelodysplastic Syndromes | 4 |
| Anemia, Sickle Cell | 2 |
| Genetic Diseases, Inborn | 2 |
| Hematologic Diseases | 2 |
| Hemochromatosis | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.